Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.3%

3 terminated out of 69 trials

Success Rate

89.7%

+3.1% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

15%

4 of 26 completed with results

Key Signals

4 with results90% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (14)
Early P 1 (2)
P 1 (19)
P 2 (8)
P 3 (1)
P 4 (5)

Trial Status

Unknown26
Completed26
Active Not Recruiting5
Recruiting4
Terminated3
Withdrawn3

Trial Success Rate

89.7%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (69)

Showing 20 of 20 trials
NCT03816852Phase 2SuspendedPrimary

The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency

NCT04675970Completed

Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy

NCT02467231Active Not Recruiting

Ovarian Reserve After Cancer: Longitudinal Effects

NCT05890417Not ApplicableRecruitingPrimary

Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy

NCT05462379Phase 1Active Not Recruiting

Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.

NCT06117982Phase 2Completed

The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency

NCT04381299Active Not Recruiting

Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?

NCT04390308Recruiting

Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?

NCT03381300Not ApplicableActive Not Recruiting

Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome

NCT04815213Phase 1Active Not RecruitingPrimary

The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans

NCT04031456Phase 2Recruiting

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

NCT05740579Not ApplicableRecruiting

The Danish TURNER Cryopreservation Study

NCT04536467Phase 2Enrolling By InvitationPrimary

Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients

NCT06202547Phase 1UnknownPrimary

Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure

NCT04189406Unknown

Turner Syndrome Minipuberty Study

NCT06132542Phase 1UnknownPrimary

Autologous ADMSC Transplantation in Patients With POI

NCT06121388UnknownPrimary

Brain MRI Imaging Changes and Associated Factors on Cognition Function in Patients With Premature Ovarian Failure

NCT05838157Unknown

The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age

NCT00837616Phase 4Completed

Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism

NCT04071574Phase 1Completed

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Scroll to load more

Research Network

Activity Timeline